Skip to content

Multicentre Evaluation of Management Protocol for Chronic Cough in Children

Does the use of a standardised protocol for the treatment of chronic cough in children improve clinical outcomes by the 6 week timepoint?

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12607000526471
Acronym
MSCAPE
Enrollment
250
Registered
2007-10-11
Start date
2007-03-19
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The primary purpose of this study is to evaluate the use of a management protocol designed to improve the management of children with chronic cough. Cough that lasts greater than 4 weeks in children has been shown to cause considerable anxiety to parents and presents a major management problem to the treating doctor. This study aims to prove the hypothesis that the management of chronic cough in children in accordance with a management protocol is feasible and efficient, and improves clinical outcomes.

Interventions

Participants in the project will be treated in accordance with a standardised protocol (flowchart). Participants will be asked to complete validated quality of life questionnaires at point of referral, 6 weeks, 10 weeks, 14 weeks, 26 weeks and 52 weeks, or until such point as the cough has ceased. Participants will be randomised to active arm (consultation and treatment according to flowchart within 2 weeks of referral) or control arm (consultation and treatment according to flowchart accordin

Participants in the project will be treated in accordance with a standardised protocol (flowchart). Participants will be asked to complete validated quality of life questionnaires at point of referral, 6 weeks, 10 weeks, 14 weeks, 26 weeks and 52 weeks, or until such point as the cough has ceased. Participants will be randomised to active arm (consultation and treatment according to flowchart within 2 weeks of referral) or control arm (consultation and treatment according to flowchart according to usual waiting time of instituition/practitioner, usually 6 weeks).

Sponsors

Prof Anne Chang
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
-2147483648 N/A to 18 Years
Healthy volunteers
No

Inclusion criteria

Child (aged 0-18 years) newly referred to participating study physician for investigation/treatment of cough that has persisted for greater than 4 weeks.

Exclusion criteria

Nil

Outcome results

None listed

Source: ANZCTR · Data processed: Mar 30, 2026